Shilanski & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,795
| Closed | -$2.93M | – | 108 |
|
|
2024
Q4 | $2.93M | Buy |
3,795
+21
| +0.6% | +$16.2K | 0.94% | 35 |
|
|
2024
Q3 | $3.34M | Buy |
3,774
+130
| +4% | +$115K | 1.09% | 33 |
|
|
2024
Q2 | $3.3M | Sell |
3,644
-122
| -3% | -$110K | 1.11% | 31 |
|
|
2024
Q1 | $2.93M | Sell |
3,766
-161
| -4% | -$125K | 1.01% | 32 |
|
|
2023
Q4 | $2.29M | Sell |
3,927
-8
| -0.2% | -$4.66K | 0.87% | 38 |
|
|
2023
Q3 | $2.11M | Sell |
3,935
-3
| -0.1% | -$1.61K | 0.86% | 39 |
|
|
2023
Q2 | $1.85M | Buy |
3,938
+97
| +3% | +$45.5K | 0.75% | 40 |
|
|
2023
Q1 | $1.39M | Buy |
3,841
+87
| +2% | +$31.5K | 0.63% | 41 |
|
|
2022
Q4 | $1.37M | Buy |
3,754
+2,729
| +266% | +$998K | 0.6% | 43 |
|
|
2022
Q3 | $331K | Buy |
+1,025
| New | +$331K | 0.12% | 89 |
|